The World Health Organization said on Friday it had reached an agreement with Pfizer/BioNTech for 40 million doses of its COVID-19 vaccine and should be able to start delivering vaccines to poor and lower-middle income countries next month under its ...
The variant of the new coronavirus identified in South Africa can resist, or "escape," antibodies that neutralize earlier versions of the virus, scientists have found....
Scientists are reporting troubling signs that some recent mutations of the virus that causes COVID-19 may modestly curb the effectiveness of two current vaccines, although they stress that the shots s...
Pakistan’s planning minister says the country’s drug regulatory authority has approved the use of Oxford-AstraZeneca’s COVID-19 vaccine and the government is trying to make it available by the first quarter of the year....
People who have had COVID-19 are highly likely to have immunity to it for at least five months but there is evidence that those with antibodies may still be able to carry and spread the virus, a UK st...
Nearly half of staff working in intensive care units (ICU) in England in the COVID-19 pandemic have severe anxiety, depression or post-traumatic stress disorder, with some reporting feeling they’d b...
Most patients hospitalized with COVID-19 have at least one symptom six months after falling ill, according to findings from a study in Wuhan, China, where the novel coronavirus first emerged in late 2019....
The new variant of the coronavirus first detected in Britain has been confirmed in northern Mexico, health officials said on Sunday, adding a new layer of concern to an already severe national outbrea...
With COVID-19 surging and vaccinations off to a slow start, President-elect Joe Biden will rapidly release most available vaccine doses to protect more people, his office said Friday, a reversal of Tr...
GENEVA: The head of the World Health Organization said on Friday there is a “clear problem” that low- and middle-income countries are not yet receiving...
The new coronavirus does not need to directly invade brain tissue to damage it, a new study suggests....
The European Union’s executive commission gave the green light Wednesday to Moderna Inc.’s COVID-19 vaccine, providing the 27-nation bloc with a second vaccine to use in the desperate battle to ta...
The US could soon be giving at least a million COVID-19 vaccinations a day despite the sluggish star...
Britain must vaccinate two million people a week to avoid a third wave of the coronavirus outbreak, ...
Two new studies give encouraging evidence that having COVID-19 may offer some protection against fut...
Moderna Inc said on Wednesday it expects that the immunity induced by its COVID-19 vaccine would be ...
British drugmaker AstraZeneca Plc told Reuters on Tuesday its COVID-19 vaccine should be effective a...
The first shots in a massive US COVID-19 vaccine campaign will be administered as early as Monday, w...
The US Food and Drug Administration said it authorized the use of Pfizer Inc’s COVID-19 vaccine on...
Pfizer's COVID-19 vaccine faces one final hurdle as it races to become the first shot greenlighted i...
The United Arab Emirates said Wednesday a Chinese coronavirus vaccine tested in the federation of sh...
Margaret Keenan, a 90-year-old grandmother from Britain, has become the first person in the world to...
UK health authorities are rolling out the first doses of a widely tested and independently reviewed ...
Pfizer Inc has applied for emergency use authorisation of its coronavirus vaccine in India, media sa...
The European Union drug agency said Tuesday it may need four more weeks to approve its first coronav...
Britain said Sunday it has secured 2 million more doses of a promising coronavirus vaccine as it gea...
Deaths from malaria due to disruptions during the coronavirus pandemic to services designed to tackl...
People have a tendency not to believe in vaccines when they learn about them online or through frien...
People whose immune systems responded strongly to a measles-mumps-rubella (MMR) vaccine may be less ...
Pfizer formally asked US regulators Friday to allow emergency use of its COVID-19 vaccine, starting ...
People who've had COVID-19 are highly unlikely to contract it again for at least six months after th...
Pfizer Inc and BioNTech could secure emergency U.S. and European authorization for their COVID-19 v...
A second experimental COVID-19 vaccine — this one from Moderna Inc. — yielded extraordinarily st...
Vaccine developers globally are scrambling to work out how to ship and store their vials, some of wh...
